Vyalev Interactions
There are 497 drugs known to interact with Vyalev (foscarbidopa/foslevodopa), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 50 are major, 445 are moderate, and 2 are minor.
- View all 497 medications that may interact with Vyalev
- View Vyalev alcohol/food interactions (1)
- View Vyalev disease interactions (1)
Most frequently checked interactions
View interaction reports for Vyalev (foscarbidopa / foslevodopa) and the medicines listed below.
- amantadine
- Andembry (garadacimab)
- azelastine nasal
- budesonide nasal
- carbidopa / levodopa
- Evenity (romosozumab)
- fluticasone nasal
- Fosamax (alendronate)
- gabapentin
- Gemtesa (vibegron)
- hydroxyzine
- ibuprofen
- levodopa
- levothyroxine
- Linzess (linaclotide)
- lorazepam
- magnesium citrate
- magnesium oxide
- MiraLAX (polyethylene glycol 3350)
- naproxen
- Neupro (rotigotine)
- omeprazole
- pramipexole
- prednisone
- Prolia (denosumab)
- rasagiline
- ropinirole
- Rytary (carbidopa / levodopa)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Vyalev alcohol/food interactions
There is 1 alcohol/food interaction with Vyalev (foscarbidopa / foslevodopa).
Vyalev disease interactions
There is 1 disease interaction with Vyalev (foscarbidopa / foslevodopa) which include:
Report options
QR code containing a link to this page
More about Vyalev (foscarbidopa / foslevodopa)
- Vyalev consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.